Liezel Bersamina
Family · Fair Oaks, CANPI 1912310046
Payments from drug & device makers
Across 266 payments — averaging $15.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Lilly USA, LLC$930
- Amgen$275
- Abbott$274
- AstraZeneca$222
- Boehringer Ingelheim$210
- plus $935 from 19 others
What the payments were for
- Food & beverage$4,120100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 103 | $1,274 |
| Lilly USA, LLC | 68 | $930 |
| Amgen | 15 | $275 |
| Abbott | 18 | $274 |
| AstraZeneca(2 entities) | 6 | $222 |
| Boehringer Ingelheim | 10 | $210 |
| Esperion Therapeutics, Inc. | 12 | $182 |
| Sanofi-aventis U.S. LLC | 4 | $101 |
| BD | 3 | $93 |
| Medtronic | 4 | $88 |
| Currax Pharmaceuticals LLC | 5 | $83 |
| Mannkind Corporation | 4 | $68 |
| Zealand Pharma US, Inc. | 2 | $56 |
| Exact Sciences | 1 | $32 |
| AbbVie | 1 | $30 |
| Radius Health, Inc. | 1 | $27 |
| Amarin Pharma, Inc. | 1 | $24 |
| Corcept Therapeutics | 1 | $24 |
| Merck | 1 | $23 |
| BETA Bionics, Inc. | 1 | $23 |
| Ascendis Pharma Endocrinology Inc | 1 | $20 |
| IBSA Pharma Inc. | 1 | $19 |
| Kyowa Kirin, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Insulet Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,120 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 26 | $31,687 |
| EliquisApixaban | 30 | $20,565 |
| Tresiba Flextouch U-200Insulin Degludec | 18 | $14,130 |
| SynthroidLevothyroxine Sodium | 35 | $3,540 |
| Humalog Kwikpen U-100Insulin Lispro | 12 | $2,036 |
| Atorvastatin Calcium | 132 | $1,448 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 49 | $1,243 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $1,182 |
| Levothyroxine Sodium | 86 | $1,053 |
| Losartan Potassium | 58 | $1,009 |
| Omeprazole | 48 | $998 |
| Rosuvastatin Calcium | 39 | $576 |
| Gabapentin | 34 | $453 |
| Amlodipine Besylate | 43 | $452 |
| Ibandronate Sodium | 18 | $439 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $210 | $31,68726 claims |
| AbbVieSynthroid | $30 | $3,54035 claims |
| Lilly USA, LLCOlanzapine | $930 | $13711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,634 family providers in California.
Other family in Fair Oaks
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.